Updates are available Correction dated 2026-03-03
Click to view Correction: https://doi.org/10.1038/s41431-026-02064-3
-
Authors
Tanha, Hamzeh M. https://orcid.org/0000-0003-0818-3481
Law, Matthew H.
Ingold, Nathan
Olsen, Catherine M.
Pandeya, Nirmala
Milne, Roger L. https://orcid.org/0000-0001-5764-7268
MacInnis, Robert J.
Whiteman, David C. https://orcid.org/0000-0003-2563-9559
Cust, Anne E. https://orcid.org/0000-0002-5331-6370
Steinberg, Julia https://orcid.org/0000-0002-0585-2312
- License Information
-
More Information
Article History
Received: 16 July 2025
Revised: 10 November 2025
Accepted: 11 December 2025
First Online: 13 January 2026
Change Date: 2 March 2026
Change Type: Update
Change Details: The original online version of this article was revised: In Table 1 cell sizes ≤5 were suppressed to preserve confidentiality. The same was done in Table S2, page 20 of the supplementary information file, with relevant other cells (denoted by ^), rounded to ensure the suppressed cells cannot be derived from the remaining information.
Change Date: 3 March 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41431-026-02064-3
Competing interests
: The authors declare no competing interests.
: All participants in the UKB, QSkin and MCCS cohorts provided informed consent. The UKB study received approval from the Northwest Centre for Research Ethics Committee (Approval Reference: 11/NW/0382), QSkin was approved by the QIMR Berghofer Medical Research Institute Human Research Ethics Committee (Approval Numbers: P1309 and P2034) and MCCS by the Cancer Council Victoria Human Research Ethics Committee. This research utilised the UK Biobank Resource under Application Number 61181.
